Tag Archives: business

Takeda Launches New Plan, Cuts US Jobs

By George Koroneos | Published: May 13, 2010
Image via Wikipedia The Japanese are taking a play from the US pharmaceutical industry’s rulebook and restructuring itself under the auspices of a fun catch phrase: “Transformation for a New Takeda.” The punch line, however, isn’t too funny. According to a two-year mid-range plan announced yesterday, Takeda will cut about 1,400 positions in the US to fend off [...]
Posted in Strategy | Also tagged , , , , , , , | Leave a comment

A Crash Course in SaaS

By Oriana Schwindt | Published: May 12, 2010
Image via Wikipedia Our magazine is called Pharmaceutical Executive—indicating a focus on the c-suite. But we know many of our readers aren’t executives (yet), and may not have quite the same in-depth knowledge as their bosses. So, for those who hear the term “SaaS” bandied about in conversations and fake their way through discussions about it [...]
Posted in Strategy | Also tagged , , , , , , | Leave a comment

BIO Convention: Potemkin Pavilions and the Power of NICE

By William Looney | Published: May 11, 2010
Image by Getty Images via Daylife Last week’s annual meeting of BIO in Chicago once again proved illustrative in showcasing the high profile that governments now plays as the biotech sector’s chief advocate. While private venture capitalists confined themselves to the margins of the meeting, the Convention hall was bursting at the seams with host [...]
Posted in Biotech | Also tagged , , , , , , | Leave a comment

Merck Shows Off Bevy of New Drugs

By George Koroneos | Published: May 6, 2010
Image by Chemical Heritage Foundation via Flickr While Merck’s net profits might be a little low in the wake of the Schering-Plough merger, it’s pipeline—and future sales—are far from bleak. According to a new report from analyst firm Deutsche Bank, Merck has no less than 18 drugs in Phase III development, with three slated for launch within [...]
Posted in R&D, Strategy | Also tagged , , , , , | Leave a comment

Webcast: SaaS or On-premise CRM—It’s Your Choice… Not Your Vendor’s

By George Koroneos | Published: April 8, 2010
Tuesday, April 13, 2010 at 11:00 AM ET; 8:00 AM PT; 16:00 GMT As the life sciences industry continues to grow in complexity, its commercial model is changing too. The traditional ’single message to many’ approach to delivering your product information has been re-focused to building and maintaining relationships to achieve lasting share of mind. Given [...]
Posted in Webcast | Also tagged , , , , , , | Leave a comment